Cleared Traditional

VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428

K010550 · bioMerieux, Inc. · Immunology
Apr 2001
Decision
57d
Days
Class 2
Risk

About This 510(k) Submission

K010550 is an FDA 510(k) clearance for the VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428, a Prostate-specific Antigen (psa) For Management Of Prostate Cancers (Class II — Special Controls, product code LTJ), submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on April 24, 2001, 57 days after receiving the submission on February 26, 2001. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K010550 FDA.gov
FDA Decision Cleared SESE
Date Received February 26, 2001
Decision Date April 24, 2001
Days to Decision 57 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code LTJ — Prostate-specific Antigen (psa) For Management Of Prostate Cancers
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — LTJ Prostate-specific Antigen (psa) For Management Of Prostate Cancers

All 33
Atellica IM Total PSA II (tPSAII)
K251630 · Siemens Healthcare Diagnostics, Inc. · Jan 2026
FREND PSA PLUS (reagent cartridge)
K162378 · Nanoentek USA, Inc. · May 2017
FREND PSA PLUS (REAGENT CARTRIDGE)
K124056 · Nanoentek, Inc. · May 2013
TPSA FLEX REAGENT CARTRIDGE
K031343 · Dade Behring, Inc. · May 2003
PROSTATE SPECIFIC ANTIGEN (PSA) ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM
K022177 · Bayer Diagnostics Corp. · Dec 2002
COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM
K022288 · Bayer Corp. · Dec 2002